Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
21.45
-0.02 (-0.09%)
At close: Apr 16, 2026, 4:00 PM EDT
21.49
+0.04 (0.19%)
Pre-market: Apr 17, 2026, 4:05 AM EDT
DAWN Market Cap
DAWN has a market cap or net worth of $2.22 billion as of April 17, 2026. Its market cap has increased by 187.32% in one year.
Market Cap
2.22B
Enterprise Value
1.78B
1-Year Change
187.32%
Ranking
Category
Stock Price
$21.45
Market Cap Chart
Since the IPO on May 27, 2021, DAWN's market cap has increased from $965.40M to $2.22B, an increase of 129.56%. That is a compound annual growth rate of 18.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 2.22B | 131.59% |
| Dec 31, 2025 | 956.94M | -25.11% |
| Dec 31, 2024 | 1.28B | 0.54% |
| Dec 29, 2023 | 1.27B | -19.71% |
| Dec 30, 2022 | 1.58B | 51.68% |
| Dec 31, 2021 | 1.04B | 8.09% |
| May 27, 2021 | 965.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nektar Therapeutics | 2.41B |
| Ultragenyx Pharmaceutical | 2.41B |
| Definium Therapeutics | 2.24B |
| Sarepta Therapeutics | 2.22B |
| Adaptive Biotechnologies | 2.17B |
| Aurinia Pharmaceuticals | 2.10B |
| Syndax Pharmaceuticals | 2.10B |
| Stoke Therapeutics | 2.09B |